Pyoderma Gangrenosum in Patients with Palmoplantar Pustulosis Treated with Brodalumab: A Case Series
Brodalumab is approved for the treatment of palmoplantar pustulosis (PPP)—a chronic, immune-mediated skin disease—in Japan. A recent phase 3 randomized clinical trial and its open-label extension evaluated the long-term efficacy and safety of brodalumab over 68 weeks, in Japanese patients with PPP. This case series details the cases of pyoderma gangrenosum (PG), a rare, neutrophilic dermatosis, that were reported during the trial. Clinical and histopathological findings were reviewed for five patients with PPP who developed PG during or after brodalumab treatment in the phase 3 trial and its 68-week extension. All affected patients were female and aged 40–70 years without any other PG-associated medical conditions. Development of PG was observed at 61–345 days after treatment initiation. Brodalumab was discontinued after onset of PG, except in case 3. Prednisolone treatment was administered, except in case 4, with all cases showing improvement. PG may present as a rare condition in patients receiving brodalumab for PPP; the detailed mechanisms remain unclear, but early recognition and appropriate management is crucial. The open-label extension study was registered as NCT04061252.
Authors
- Ryoko Shimada‐Omori
- Tadashi Terui (ORCID: https://orcid.org/0000-0002-0275-4311)
- Yukari Okubo (ORCID: https://orcid.org/0000-0002-9526-1259)
- Junichi Furuta (ORCID: https://orcid.org/0000-0002-3502-5780)
- Masamoto Murakami (ORCID: https://orcid.org/0000-0003-3923-5096)
- Satomi Kobayashi (ORCID: https://orcid.org/0000-0003-3572-2313)
- Ryusuke Ono
- Kenta Shishido (ORCID: https://orcid.org/0009-0001-4364-1399)
- Maiko Kato (ORCID: https://orcid.org/0009-0004-9216-5319)
- Taiki Udagawa
Institutions
- Nihon University (JP)
- University of Miyazaki (JP)
- University of Tsukuba (JP)
- Tokyo Medical University (JP)
- Tohoku University (JP)
- Kyowa Kirin (Japan) (JP)
- Osaka Minami Medical Center (JP)
- Kobe University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1007/s13555-026-01969-7
- Primary Topic
- Autoimmune and Inflammatory Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00